Rubric Capital Management (New York)’s Cellebrite CLBT Stock Holding History

Rubric Capital Management (New York)’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-408,192	Closed	-$2.49M	–	63
2023 Q1	$2.49M	Sell	408,192 -220,828	-35%	-$1.2M	0.06%	66
2022 Q4	$2.74M	Hold	629,020	–	–	0.12%	83
2022 Q3	$2.47M	Hold	629,020	–	–	0.12%	76
2022 Q2	$3.21M	Hold	629,020	–	–	0.17%	71
2022 Q1	$4.03M	Buy	+629,020	New	+$4.17M	0.15%	63

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return

Crosslink Capital Menlo Park, California $1.35B AUM 35.86% 1-Year Est. Return

Isomer Partners New York $74.3M AUM 23.95% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $903M AUM 113.12% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

MCM

Makena Capital Management Menlo Park, California $952M AUM 13.93% 1-Year Est. Return

Rubric Capital Management (New York)'s CLBT Position: Q2 2023 in Review

Rubric Capital Management (New York) sold out of Cellebrite (CLBT) in Q2 2023, closing a stake of 408,192 shares — an estimated $2.49M sold.

Rubric Capital Management (New York) first reported a position in CLBT in Q1 2022 and held it in 5 quarters. The position peaked at $4.03M in Q1 2022. 78 funds tracked by Wall St. Rank hold CLBT as of Q2 2023.

Rubric Capital Management (New York) reported no remaining Cellebrite position as of Q2 2023 after selling out during the quarter.
Rubric Capital Management (New York) sold 408,192 Cellebrite shares in Q2 2023, an estimated $2.49M.
Rubric Capital Management (New York) first reported a position in Cellebrite in Q1 2022 and held it in 5 quarters.
Rubric Capital Management (New York)'s Cellebrite position peaked at $4.03M in Q1 2022.
78 funds tracked by Wall St. Rank held Cellebrite as of Q2 2023.

Based on Rubric Capital Management (New York)'s 13F filing for Q2 2023, filed 11 Aug 2023.